Press Releases

First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- S

DALLAS, Nov. 21, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that Winston Black, Chief Executive Officer of SWK, has been named Chairman of the Company's Board of Directors.  Mike Weinberg, SW

HOUSTON, Nov. 21, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has entered into a Cooperative Development Agreeme

HOUSTON, Nov. 21, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, filed a Pre-IND meeting request for Berubicin for IV for the Treatment of Glioblastoma Multiforme to the US Food and Drug Administration Division of Oncology Products 2, C

HARRISBURG, Pa., Nov. 21, 2019 /PRNewswire/ -- In a continued effort to help Pennsylvanians suffering from addiction, the state's largest physician organization agreed to endorse the opening of independently funded pilot programs to study the effectiveness of safe injection sites.

STOCKHOLM, Nov. 21, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company has signed an agreement with a UK contract research organization (CRO) to conduct the six-month toxicology studies with Rabeximod as required ahead of the Phase IIb study. Preparations for the toxicology studies began immediately with a pl

DALLAS, Nov. 21, 2019 /PRNewswire/ -- The end of the year is always a busy time with the holidays in full swing, so it's easy to forget your vision insurance benefits expiring on December 31. In most cases, unused vision insurance benefits and flex spending accounts from this year cannot be transferred over to the new year. That's why

PHOENIX, Nov. 21, 2019 /PRNewswire/ -- University of Phoenix today announced survey findings regarding active-

SAN FRANCISCO, Nov. 21, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Shelly Guyer, chief

SEATTLE, Nov. 21, 2019 /PRNewswire/ -- Immunexpress, Inc. today announced the U.S. Patent and Trademark Office (USPTO) has granted Patent No. U.S. 10,364,474 B2, which covers single nucleotide p